Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:1063-1072
doi: 10.1161/CIRCULATIONAHA.104.524371
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Homma, S.
Right arrow Articles by Sacco, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Homma, S.
Right arrow Articles by Sacco, R. L.
Related Collections
Right arrow Echocardiography
Right arrow Embolic stroke
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Other Stroke

(Circulation. 2005;112:1063-1072.)
© 2005 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Patent Foramen Ovale and Stroke

Shunichi Homma, MD; Ralph L. Sacco, MD

From the Division of Cardiology (S.H.) and Neurological Institute (R.L.S.), Columbia University, New York, NY.

Correspondence to Shunichi Homma, MD, Division of Cardiology, Columbia University, College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032. E-mail sh23@columbia.edu


Key Words: anticoagulants • aspirin • embolism • heart septal defects, atrial • stroke


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
This review summarizes the current state of knowledge about the relationship of patent foramen ovale (PFO) with ischemic stroke. Initial sections discuss the studies that identified this association. Subsequent sections discuss the detection techniques for PFO and other variables that may cause a PFO to be a conduit of paradoxical embolization. Finally, a section is devoted to summarizing the studies that assessed the strategies for preventing recurrent ischemic events in patients with PFO.


*    Cryptogenic Stroke and PFO
 
In {approx}40% of patients with acute ischemic stroke, the cause remains undefined.1 PFO is a hemodynamically insignificant interatrial communication present in >25% of the adult population. During fetal life, because the lungs do not receive blood flow, blood returning to the right atrium is shunted through a PFO to the left atrium. Postnatally, PFO closes spontaneously in {approx}75% of the population. However, in a portion of adults, by maintaining a direct communication between the right- and left-sided circulation, PFO can serve as a conduit for paradoxical embolization.

In 1877, Cohnheim2 described the association of PFO with stroke in a young woman with cerebral arterial embolism. However, it has been difficult to diagnose PFO in vivo until the development of echocardiography and its ability to image the interatrial shunting with an injection of saline contrast. With the use of contrast echocardiography, a strong association of cryptogenic stroke with PFO has become evident in patients <55 years of age (Table 1).3–8


View this table:
[in this window]
[in a new window]
 
TABLE 1. Relationship of Cryptogenic Stroke With PFO in Younger and Older Patients

Because stroke occurs . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
I. Monte, S. Grasso, S. Licciardi, and L. P. Badano
Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale
Eur J Echocardiogr, November 28, 2009; (2009) jep195v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. A. Alsheikh-Ali, D. E. Thaler, and D. M. Kent
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Stroke, July 1, 2009; 40(7): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory
J. Am. Coll. Cardiol., May 26, 2009; 53(21): 2014 - 2018.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory.
Circulation, May 26, 2009; 119(20): 2743 - 2747.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
M. A. Ford, G. S. Reeder, R. J. Lennon, R. D. Brown, G. W. Petty, A. K. Cabalka, F. Cetta, and D. J. Hagler
Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack: The Mayo Clinic Experience
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 404 - 411.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
K. Yared, A. L. Baggish, J. Solis, R. Durst, J. J. Passeri, I. F. Palacios, and M. H. Picard
Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications
Circ Cardiovasc Imaging, March 1, 2009; 2(2): 141 - 149.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
A. Wahl, T. Tai, F. Praz, M. Schwerzmann, C. Seiler, K. Nedeltchev, S. Windecker, H. P. Mattle, and B. Meier
Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography: Effect of Device Size
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
P. Sorajja and R. A. Nishimura
Patent Foramen Ovale Closure Without Echocardiography: Are We Closing the Door Too Fast Too Soon?
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 124 - 126.
[Full Text] [PDF]


Home page
CirculationHome page
S. Windecker and B. Meier
Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else!
Circulation, November 4, 2008; 118(19): 1989 - 1997.
[Full Text] [PDF]


Home page
CirculationHome page
S. R. Messe and S. E. Kasner
Patent Foramen Ovale in Cryptogenic Stroke: Not to Close
Circulation, November 4, 2008; 118(19): 1999 - 2004.
[Full Text] [PDF]


Home page
RadiologyHome page
F. Saremi, S. Channual, A. Raney, S. V. Gurudevan, J. Narula, S. Fowler, A. Abolhoda, and J. C. Milliken
Imaging of Patent Foramen Ovale with 64-Section Multidetector CT
Radiology, November 1, 2008; 249(2): 483 - 492.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
K. Le Doare, S. Ameli-Renani, D. Banerjee, S. J. D. Brecker, and J. B. Eastwood
Acute renal failure and multiple sites of ischaemia: what is the unifying diagnosis?
NDT Plus, October 1, 2008; 1(5): 359 - 360.
[Full Text] [PDF]


Home page
ChestHome page
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 593S - 629S.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Bhindi and O. J. Ormerod
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect
JAMA, May 21, 2008; 299(19): 2272 - 2272.
[Full Text] [PDF]


Home page
JAMAHome page
A. R. Opotowsky, M. J. Landzberg, and G. D. Webb
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect--Reply
JAMA, May 21, 2008; 299(19): 2272 - 2273.
[Full Text] [PDF]


Home page
NEJMHome page
M. A. Meyer, C. Kunavarapu, J. A. Switzer, F. Nichols III, B. Silver, A. Russman, D. M. Kent, T. A. Trikalinos, D. E. Thaler, M. Handke, et al.
Patent Foramen Ovale and Cryptogenic Stroke
N. Engl. J. Med., April 3, 2008; 358(14): 1518 - 1521.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
D Kenny, M Turner, and R Martin
When to close a patent foramen ovale
Arch. Dis. Child., March 1, 2008; 93(3): 255 - 259.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
R. K. Mareedu, M. S. Shah, J. E. Mesa, and C. S. McCauley
Percutaneous Closure of Patent Foramen Ovale: A Case Series and Literature Review
Clin. Med. Res., December 1, 2007; 5(4): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Meier
Patent Foramen Ovale, Guilty But Only as a Gang Member and for a Lesser Crime
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 446 - 448.
[Full Text] [PDF]